Chronic diseases account for nearly three-fourths of all global deaths. Experts say many of these deaths can be prevented, ...

WAVE Life Sciences Ltd (WVE) showcases significant progress in RNA technologies and a strong financial position, despite ...

NPPA revokes its earlier direction refusing discontinuation of GSK's antifungal formulation: Gireesh Babu, New Delhi Saturday ...

Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by ...

Rosnilimab was safe and well tolerated with similar adverse event rates vs. placeboObserved expected pharmacology, including ~90% depletion of ...

Eli Lilly's weight-loss therapy Mounjaro became India's top-selling drug by value in October, data showed on Friday, ...

At a recent lunch in Melbourne, two dozen luminaries exchanged war stories about their two decades-plus involvement in the ...

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by their role in targeting DNA repair vulnerabilities.

Direct-to-consumer drug advertising is already the most heavily regulated form of commercial speech in America. It does not need more.

Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...